- Business Wire•11 months ago
As previously reported, NovaDel Pharma Inc. sold its ZolpiMist® assets to Amherst Pharmaceuticals, Inc. principally in exchange for the assumption of Novadel’s FDA liabilities of approximately $2.2 million.
We're sorry this is all we were able to find about this topic.
NVDL : Summary for NOVADEL PHARMA INC COM USD0.01 - Yahoo Finance
Novadel Pharma Inc. (NVDL)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Bid||0.00 x 5000|
|Ask||0.01 x 5000|
|Day's Range||0.01 - 0.01|
|52 Week Range||0.00 - 0.01|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.22|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|